Skip to main content
SpringerLink
Log in

Pain Management for Gastroparesis

  • Chapter
  • First Online:
Gastroparesis

Part of the book series: Clinical Gastroenterology ((CG))

  • 1616 Accesses

Abstract

In some patients with gastroparesis, abdominal pain can be a prominent component of their symptoms. Treatment of abdominal pain, as well as any type of pain, in patients with gastroparesis is difficult, as some of the treatments may impact adversely on gastric emptying and other symptoms of gastroparesis. This chapter discusses the symptom of abdominal pain in gastroparesis and the management of pain in patients with gastroparesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592–622.

    Article  PubMed  Google Scholar 

  2. Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum R. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–404.

    Article  PubMed  CAS  Google Scholar 

  3. Tack J, Talley NJ, Camilleri M, Holtmann G, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–79.

    Article  PubMed  Google Scholar 

  4. Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil. 2010;22(2):113–33.

    Article  PubMed  CAS  Google Scholar 

  5. Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, et al. National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140(1):101–15.

    Article  PubMed  Google Scholar 

  6. Reddymasu SC, McCallum RW. Pharmacotherapy of gastroparesis. Expert Opin Pharmacother. 2009;10:469–84.

    Article  PubMed  CAS  Google Scholar 

  7. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, McCallum RW, et al. Consensus recommendations for gastric emptying scintigraphy. A joint report of the Society of Nuclear Medicine and The American Neurogastroenterology and Motility Society. Am J Gastroenterol. 2008;103:753–63.

    Article  PubMed  Google Scholar 

  8. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, et al. Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004;13:833–44.

    Article  PubMed  Google Scholar 

  9. Revicki DA, Camilleri M, Kuo B, Norton NJ, Murray L, Palsgrove A, et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. APT. 2009;30:670–80.

    CAS  Google Scholar 

  10. Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004;13:1737–49.

    Article  PubMed  CAS  Google Scholar 

  11. Bielefeldt K, Raza N, Zickmund SL. Different faces of gastroparesis. World J Gastroenterol. 2009;28:6052–60.

    Article  Google Scholar 

  12. Karamanolis G, Caenepeel P, Arts J, Tack J. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut. 2007;56:29–36.

    Article  PubMed  CAS  Google Scholar 

  13. Hoogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol. 1999;94:1029–33.

    Article  PubMed  CAS  Google Scholar 

  14. Cherian D, Sachdeva P, Fisher RS, Parkman HP. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol. 2010;8(8):676–81.

    Article  PubMed  Google Scholar 

  15. Hasler WL, Wilson L, Parkman HP, Koch KL, Abell TL, Pasricha PJ, et al. Importance of abdominal pain as a symptom in gastroparesis: relation to clinical factors, disease severity, quality of life, gastric retention, and medication use. Gastroenterology. 2010;138 Suppl 1:S461. abstract.

    Google Scholar 

  16. Stanghellini V, Tosetti C, Horowitz M, De Giorgio R, Barbara G, Cogliandro R, et al. Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms. Dig Liver Dis. 2003;35:389–96.

    Article  PubMed  CAS  Google Scholar 

  17. Kindt S, Dubois D, Van Oudenhove L, Caenepeel P, Arts J, Bisschops R, et al. Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil. 2000;21:1183–9.

    Article  Google Scholar 

  18. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001;121:526–35.

    Article  PubMed  CAS  Google Scholar 

  19. Rathmann W, Enck P, Frieling T, Gries FA. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care. 1991;14:1086–9.

    Article  PubMed  CAS  Google Scholar 

  20. van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Dirix S, et al. Regional brain activity in functional dyspepsia. Gastroenterology. 2010;139:36–47.

    Article  PubMed  Google Scholar 

  21. Abell TL, Bernstein RK, Cutts T, Farrugia G, Forster J, Hasler WL, et al. Treatment of gastroparesis: a multidisciplinary review. Neurogastroenterol Motility. 2006;18:263–83.

    Article  CAS  Google Scholar 

  22. Tack J, Lee KJ. Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol. 2005;39(5 Suppl 3):S211–6.

    Article  PubMed  Google Scholar 

  23. Saad RJ, Chey WD. Review article: current and emerging therapies for functional dyspepsia. Aliment Pharmacol Ther. 2006;24:475–92.

    Article  PubMed  CAS  Google Scholar 

  24. Braden B, Enghofer M, Schaub M, Usadel KH, Caspary WF, Lembcke B. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment Pharmacol Ther. 2002;16:1341–6.

    Article  PubMed  CAS  Google Scholar 

  25. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol. 1997;92:976–80.

    PubMed  CAS  Google Scholar 

  26. Hasler WL, Soudah HC, Dulai G, Owyang C. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology. 1995;108:727–36.

    Article  PubMed  CAS  Google Scholar 

  27. Pimentel M, Sam C, Lin HC. Indomethacin improves symptoms and electrogastrographic findings in patients with gastric dysrhythmias. Neurogastroenterol Motility. 2001;13:422. abstract.

    Google Scholar 

  28. Simonian HP, Parkman HP. Effect of prostaglandin inhibition with ketorolac on gastric activity and dyspeptic symptoms in patients with dyspeptic symptoms. Am J Gastro. 2003;98(Suppl):S58. abstract.

    Article  Google Scholar 

  29. Gorelick AB, Koshy SS, Hooper FG, et al. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol. 1998;2756:G460–6.

    Google Scholar 

  30. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci. 1994;39:2352–63.

    Article  PubMed  CAS  Google Scholar 

  31. Prakash C, Lustman PJ, Freedland KE, Clouse RE. Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients. Dig Dis Sci. 1998;43:1951–6.

    Article  PubMed  CAS  Google Scholar 

  32. Loldrup D, Langemark M, Hansen HJ, Olesen J, Beck P. Clomipramine and mianserin in chronic idiopathic pain syndrome: a placebo controlled study. Psychopharmacology. 1989;99:1–7.

    Article  PubMed  CAS  Google Scholar 

  33. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastro. 1998;93:160–5.

    Article  CAS  Google Scholar 

  34. Sawhney MS, Prakash C, Lustman PJ, Clouse RE. Tricyclic antidepressants for chronic vomiting in diabetic patients. Dig Dis Sci. 2007;52(2):418–24.

    Article  PubMed  CAS  Google Scholar 

  35. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125(1):19–31.

    Article  PubMed  Google Scholar 

  36. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116(12):109–18.

    Article  PubMed  CAS  Google Scholar 

  37. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G130–7.

    PubMed  CAS  Google Scholar 

  38. Gorard DA, Libby GW, Farthing MJ. 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut. 1994;35:496–500.

    Article  PubMed  CAS  Google Scholar 

  39. Lee H, Kim JH, Min B-H, Lee JH, Son HJ, Kim JJ, et al. Efficacy of venlafaxine for symptomatic relief in young, adult patients with functional chest pain. Am J Gastroenterol. 2010;105:1504–12.

    Article  PubMed  CAS  Google Scholar 

  40. van Kerkhoven LA, Laheij RJ, Aparicio N, De Boer WA, van den Hazel S, Tan AC, et al. Effect of the antidepressant venlafaxine in functional dyspepsia. Clin Gastroenterol Hepatol. 2008;6:746–52.

    Article  PubMed  Google Scholar 

  41. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm. 2004;61(2):160–73.

    PubMed  CAS  Google Scholar 

  42. Carroll DG, Kline KM, Malnar KF. Role of topiramate for the treatment of painful diabetic peripheral neuropathy. Pharmacotherapy. 2004;24(9):1186–93.

    Article  PubMed  CAS  Google Scholar 

  43. Eisenberg E, River Y, Shifrin A, Krivoy N. Antiepileptic drugs in the treatment of neuropathic pain. Drugs. 2007;67(9):1265–89.

    Article  PubMed  CAS  Google Scholar 

  44. Maurer AH, Krevsky B, Knight LC, Brown K. Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy. J Nucl Med. 1996;37:818–22.

    PubMed  CAS  Google Scholar 

  45. Murphy DB, Sutton A, Prescott LF, Murphy MB. A comparison of the effects of tramadol and morphine on gastric emptying in man. Anaesthesia. 1997;52:1224–9.

    Article  PubMed  CAS  Google Scholar 

  46. Crighton IM, Martin PH, Hobbs GJ, Cobby TF, Fletcher AJ, Stewart PD. A comparison of the effects of intravenous tramadol, codeine, and morphine on gastric emptying in human volunteers. Anesth Analg. 1998;87:445–9.

    PubMed  CAS  Google Scholar 

  47. Tramadol. Wikipedia, the free encyclopedia. http://en.wikipedia.org/wiki/Tramadol. Visited 12/31/2010.

  48. Mercadante S, Casuccio A, Fulfaro F, et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol. 2001;19:2898–904.

    PubMed  CAS  Google Scholar 

  49. Tawfik MO, Bryuzgin V, Kourteva G, FEN-INT-20 Study Group. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain. Curr Med Res Opinion. 2004;20:259–267.

    Google Scholar 

  50. Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Sympt Manage. 2002;23:48–53.

    Article  Google Scholar 

  51. Foss JF. A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg. 2001;182:19S–26S.

    Article  PubMed  CAS  Google Scholar 

  52. Gonenne J, Camilleri M, Ferber I, Burton D, Baxter K, Keyashian K, et al. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol. 2005;3:784–91.

    Article  PubMed  CAS  Google Scholar 

  53. Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol. 2007;5(10):1126–39.

    Article  PubMed  CAS  Google Scholar 

  54. Camilleri M. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil. 2008;20:971–9.

    Article  PubMed  CAS  Google Scholar 

  55. Huilgol V, Evans J, Hellman RS, Soergel KH. Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls. Aliment Pharmacol Ther. 2002;16(5):945–50.

    Article  PubMed  CAS  Google Scholar 

  56. Malcom A, Camilleri M, Kost L, et al. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment Pharm Therap. 2000;14:783–93.

    Article  Google Scholar 

  57. Phillips WJ, Tollefson B, Johnson A, Abell T, Lerant A. Relief of acute pain in chronic idiopathic gastroparesis with intravenous phentolamine. Ann Pharmacother. 2006;40:2032–6.

    Article  PubMed  CAS  Google Scholar 

  58. Szurszewski JH, Miller SM. Physiology of prevertebral ganglia. In: Johnson LR, editor. Physiology of the gastrointestinal tract. 3rd ed. New York: Raven Press; 1994. p. 795–877.

    Google Scholar 

  59. Singh VV, Toskes PP. Medical therapy for chronic pancreatitis pain. Curr Gastroenterol Rep. 2003;5:110–6.

    Article  PubMed  Google Scholar 

  60. Iftikhar S, Loftus EV. Gastroparesis after celiac plexus block. Am J Gastroenterol. 1998;93:2223–5.

    Article  PubMed  CAS  Google Scholar 

  61. Abell T, McCallum R, Hocking M, Koch K, Abrahamsson H, Leblanc I, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology. 2003;125:421–8.

    Article  PubMed  Google Scholar 

  62. McCallum RW, Lin Z, Forster J, Roeser K, Hou Q, Sarosiek I. Gastric Electrical Stimulation Improves Outcomes of Patients with Gastroparesis Over a 1-10-Year Time Period. Clin Gastroenterol Hepatol. 2010 Dec 22. [Epub ahead of print]

    Google Scholar 

  63. McCallum RW, Snape W, Brody F, Wo J, Parkman HP, Nowak T. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol. 2010;8(11):947–54.

    Article  PubMed  Google Scholar 

  64. McCallum RW, Snape WJ, Wo J, Brody FJ, Parkman HP, Nowak TV, Lerew DR, Ruehlow L. Enterra Gastric Electrical Stimulation for Idiopathic Gastroparesis: Results from a Multicenter Randomized Study. Gastroenterology 2010 (abstract).

    Google Scholar 

  65. Maranki JL, Lytes V, Meilahn JE, Harbison S, Friedenberg FK, Fisher RS, et al. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Dig Dis Sci. 2008;53(8):2072–8.

    Article  PubMed  Google Scholar 

  66. Takahashi T. Acupuncture for functional gastrointestinal disorders. J Gastroenterol. 2006;41:08–17.

    Google Scholar 

  67. Chiarioni G, Whitehead WE. The role of biofeedback in the treatment of gastrointestinal disorders. Nat Clin Pract Gastroenterol Hepatol. 2008;5:371–82.

    Article  PubMed  Google Scholar 

  68. Lefaucher J-P. Use of repetitive transcranial magnetic stimulation in pain relief. Expert Rev Neurother. 2008;8:799–808.

    Article  Google Scholar 

  69. Sen H, Sizlan A, Yanarates O, Emirkadi H, Ozkan S, Dagli G, et al. A comparison of gabapentin and ketamine in acute and chronic pain after hysterectomy. Pain Med. 2009;109:1645–50.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Temple University School of Medicine, Parkinson Pavilion, 8th Floor, 3401 North Broad Street, Philadelphia, PA, 19140, USA

    Henry P. Parkman MD (Gastroenterology Section)

Authors
  1. Henry P. Parkman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henry P. Parkman MD .

Editor information

Editors and Affiliations

  1. School of Medicine, Department of Medicine, Temple University, N. Broad St. 3401, Philadelphia, 19140, Pennsylvania, USA

    Henry P. Parkman

  2. Paul L Foster School of Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Ce, Alberta Avenue 4800, El Paso, 77905, Texas, USA

    Richard W. McCallum

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Parkman, H.P. (2012). Pain Management for Gastroparesis. In: Parkman, H., McCallum, R. (eds) Gastroparesis. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60761-552-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-552-1_24

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-551-4

  • Online ISBN: 978-1-60761-552-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation